Elevance Health (ELV) Financials: Revenue & Earnings

ELV price $419.46 -2.02 -0.48%

Ticker
ELV
Price
$419.46
Change
-2.02 -0.48%
Market cap ?
$90.97B
P/E ?
18.37
Forward P/E ?
14.52
Dividend yield ?
1.59%
Beta ?
0.71
Sector
Healthcare
Industry
Medical - Healthcare Plans
Stocklytics score
39
Value
49
Quality
37
Growth
32

Stocklytics score rationale: value 49, quality 37, growth 32.

Financials

2016201720182019202020212022202320242025
849784000009003940000092105000000104213000000121867000000138639000000156595000000171340000000176810000000199125000000

Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical…

Fair value

ELV fair value $619.12. Price $419.46. Price is 32% below fair value.

Below fair value, around its usual discount.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 6.51B. Growth 14.74%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 216.87M. Net debt 23.74B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare ELV

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-01-27—2.10—49.38B
2026-10-216.994.7150.44B49.28B
2026-07-157.456.2149.83B48.88B
2026-04-2212.5810.8249.49B48.20B
2026-01-283.333.1049.31B49.84B
2025-10-216.034.9350.09B49.38B
2025-07-178.848.9149.42B48.19B
2025-04-2211.9711.4148.77B46.30B
2025-01-233.843.8045.44B44.95B
2024-10-178.379.6645.15B43.47B
2024-07-1710.1210.0143.65B42.99B
2024-04-1810.6410.5342.58B42.49B
2024-01-245.625.5542.65B42.09B
2023-10-188.998.4542.85B41.97B
2023-07-199.048.8043.67B41.50B
2023-04-199.469.2642.17B40.83B
2023-01-255.235.2039.93B39.77B
2022-10-197.537.1539.94B39.29B
2022-07-208.047.7438.63B37.91B
2022-04-208.257.8138.09B37.39B
2022-01-265.145.1136.58B37.33B
2021-10-206.796.3735.82B35.30B
2021-07-217.036.3333.85B35.32B
2021-04-217.016.5132.38B29.90B
2021-01-272.542.5231.82B30.87B
2020-10-284.204.1531.16B30.79B
2020-07-299.208.8729.26B28.25B
2020-04-296.486.4829.62B29.62B
2020-01-293.883.8827.41B27.41B
2019-10-234.874.8226.67B26.40B
2019-07-244.644.6125.47B25.30B
2019-04-246.035.8124.67B23.77B
2019-01-302.442.2023.37B21.07B
2018-10-313.813.7023.25B22.58B
2018-07-254.254.1622.94B22.46B
2018-04-255.414.8822.54B20.33B
2018-01-311.291.2722.68B22.33B
2017-10-252.652.4222.43B20.48B
2017-07-263.373.2322.41B21.48B
2017-04-264.683.8622.53B18.58B

Dividends

Yield 1.64%. Payout ratio 29.17%. Frequency Quarterly.

Safety score 100/100 · Safe. Payout ratio is 29% of earnings. Dividends use less than 40% of free cash flow. Dividends were paid in 16 separate years. Yield is 1.6%, in a range that is usually sustainable.

Ex-dateDividendRecordPaymentFrequency
2026-12-04$1.722026-12-042026-12-18Quarterly
2026-09-10$1.722026-09-102026-09-25Quarterly
2026-06-10$1.722026-06-102026-06-25Quarterly
2026-03-10$1.722026-03-102026-03-25Quarterly
2025-12-05$1.712025-12-052025-12-19Quarterly
2025-09-10$1.712025-09-102025-09-25Quarterly
2025-06-10$1.712025-06-102025-06-25Quarterly
2025-03-10$1.712025-03-102025-03-25Quarterly
2024-12-05$1.632024-12-052024-12-20Quarterly
2024-09-10$1.632024-09-102024-09-25Quarterly
2024-06-10$1.632024-06-102024-06-25Quarterly
2024-03-07$1.632024-03-082024-03-22Quarterly
2023-12-05$1.482023-12-062023-12-21Quarterly
2023-09-07$1.482023-09-082023-09-22Quarterly
2023-06-08$1.482023-06-092023-06-23Quarterly
2023-03-09$1.482023-03-102023-03-24Quarterly
2022-12-02$1.282022-12-052022-12-21Quarterly
2022-09-08$1.282022-09-092022-09-23Quarterly
2022-06-09$1.282022-06-102022-06-24Quarterly
2022-03-09$1.282022-03-102022-03-25Quarterly
2021-12-02$1.132021-12-032021-12-21Quarterly
2021-09-09$1.132021-09-102021-09-24Quarterly
2021-06-09$1.132021-06-102021-06-25Quarterly
2021-03-09$1.132021-03-102021-03-25Quarterly
2020-12-04$0.952020-12-072020-12-22Quarterly
2020-09-09$0.952020-09-102020-09-25Quarterly
2020-06-09$0.952020-06-102020-06-25Quarterly
2020-03-13$0.952020-03-162020-03-27Quarterly
2019-12-04$0.802019-12-052019-12-20Quarterly
2019-09-09$0.802019-09-102019-09-25Quarterly
2019-06-07$0.802019-06-102019-06-25Quarterly
2019-03-15$0.802019-03-182019-03-29Quarterly
2018-12-04$0.752018-12-052018-12-21Quarterly
2018-09-07$0.752018-09-102018-09-25Quarterly
2018-06-07$0.752018-06-082018-06-25Quarterly
2018-03-08$0.752018-03-092018-03-23Quarterly
2017-12-04$0.702017-12-052017-12-21Quarterly
2017-09-07$0.702017-09-082017-09-25Quarterly
2017-06-07$0.652017-06-092017-06-23Quarterly
2017-03-08$0.652017-03-102017-03-24Quarterly
2016-12-01$0.652016-12-052016-12-21Quarterly
2016-09-07$0.652016-09-092016-09-26Quarterly
2016-06-08$0.652016-06-102016-06-24Quarterly
2016-03-08$0.652016-03-102016-03-25Quarterly
2015-12-02$0.622015-12-042015-12-21Quarterly
2015-09-08$0.622015-09-102015-09-25Quarterly
2015-06-08$0.622015-06-102015-06-25Quarterly
2015-03-06$0.622015-03-102015-03-25Quarterly
2014-12-03$0.442014-12-052014-12-22Quarterly
2014-09-08$0.442014-09-102014-09-25Quarterly
2014-06-06$0.442014-06-102014-06-25Quarterly
2014-03-06$0.442014-03-102014-03-25Quarterly
2013-12-05$0.382013-12-092013-12-23Quarterly
2013-09-06$0.382013-09-102013-09-25Quarterly
2013-06-06$0.382013-06-102013-06-25Quarterly
2013-03-06$0.382013-03-082013-03-25Quarterly
2012-12-05$0.292012-12-072012-12-21Quarterly
2012-09-06$0.292012-09-102012-09-25Quarterly
2012-06-06$0.292012-06-082012-06-25Quarterly
2012-03-07$0.292012-03-092012-03-23Quarterly
2011-12-07$0.252011-12-092011-12-23Quarterly
2011-09-07$0.252011-09-092011-09-23Quarterly
2011-06-08$0.252011-06-102011-06-24Quarterly
2011-03-08$0.252011-03-102011-03-25Quarterly

Insider trades

DateInsiderActionSharesPriceValue
2026-10-22Kaye MarkSell400$434.00173.60K
2026-10-22Kaye MarkSell321$435.25139.72K
2026-10-22Kaye MarkSell1.66K$436.20724.09K
2026-10-22Kaye MarkSell560$437.07244.76K
2026-10-22Kaye MarkSell240$438.22105.17K
2026-10-22Kaye MarkSell1.16K$439.25509.53K
2026-10-22Kaye MarkSell1.72K$440.44757.56K
2026-10-22Kaye MarkSell2.34K$441.341.03M
2026-10-22Kaye MarkSell480$442.61212.45K
2026-10-22Kaye MarkSell440$443.81195.28K
2026-10-22Kaye MarkSell160$444.8571.18K
2026-10-22Kaye MarkSell827$446.05368.88K
2026-10-22Kaye MarkSell273$447.19122.08K
2026-10-02Kaye MarkBuy2.63K——
2026-10-02Kaye MarkSell4.16K$386.431.61M
2026-09-03Wessling Erin MSell255$414.78105.77K
2026-09-02Wessling Erin MSell94$405.8438.15K
2026-09-02Craig Ryan RSell144$405.8458.44K
2026-07-17PERU RAMIRO GBuy1.00K$366.05366.05K
2026-07-17BOUDREAUX GAILBuy2.04K$368.25753.07K
2026-07-17BOUDREAUX GAILBuy680$366.41249.16K
2026-06-12Penczek Ronald WSell369$403.16148.77K
2026-06-11Dixon Robert L JRSell151$401.7760.67K
2026-05-19Penczek Ronald WBuy877$311.48273.17K
2026-05-19Penczek Ronald WBuy654$271.27177.41K
2026-05-19Penczek Ronald WSell1.53K$403.13617.19K
2026-05-19Penczek Ronald WSell654$271.27177.41K
2026-05-19Penczek Ronald WSell877$311.48273.17K
2026-05-13STRABLE-SOETHOUT DEANNA DBuy563——
2026-05-13SCHULMAN AMY WBuy563——
2026-05-13Schneider Ryan M.Buy563——
2026-05-13PERU RAMIRO GBuy563——
2026-05-13Neri Antonio FBuy563——
2026-05-13Jallal BahijaBuy563——
2026-05-13HAY LEWIS IIIBuy563——
2026-05-13Dixon Robert L JRBuy563——
2026-05-13DeVore Susan D.Buy563——
2026-05-13COLLIS STEVEN HBuy563——
2026-03-12SCHULMAN AMY WSell26$287.507.47K
2026-03-06Kendrick Charles Morgan JRSell3.20K$284.92910.60K
2026-03-05COLLIS STEVEN HBuy3.00K$289.84869.52K
2026-03-03Penczek Ronald WSell37$284.0310.51K
2026-03-03Wessling Erin MSell417$284.03118.44K
2026-03-03Craig Ryan RSell309$284.0387.77K
2026-03-03Norwood Felicia FSell496$284.03140.88K
2026-03-03LAVU RATNAKARSell222$284.0363.05K
2026-03-03Kendrick Charles Morgan JRSell467$284.03132.64K
2026-03-03Haytaian Peter DSell446$284.03126.68K
2026-03-03Kaye MarkSell353$284.03100.26K
2026-03-03BOUDREAUX GAILSell1.74K$284.03493.08K
2026-03-02Penczek Ronald WBuy266——
2026-03-02Penczek Ronald WBuy1.70K——
2026-03-02Penczek Ronald WBuy426——
2026-03-02Penczek Ronald WSell131$294.0738.52K
2026-03-02Penczek Ronald WBuy1.68K$294.07493.16K
2026-03-02Wessling Erin MBuy11.75K$294.073.46M
2026-03-02Wessling Erin MBuy2.98K——
2026-03-02Craig Ryan RBuy11.75K$294.073.46M
2026-03-02Craig Ryan RBuy2.98K——
2026-03-02Craig Ryan RSell25$294.077.35K
2026-03-02Norwood Felicia FBuy2.87K——
2026-03-02Norwood Felicia FBuy5.95K——
2026-03-02Norwood Felicia FSell1.42K$294.07417.87K
2026-03-02Norwood Felicia FBuy23.51K$294.076.91M
2026-03-02LAVU RATNAKARBuy20.15K$294.075.93M
2026-03-02LAVU RATNAKARBuy6.80K——
2026-03-02LAVU RATNAKARBuy5.10K——
2026-03-02LAVU RATNAKARSell315$294.0792.63K
2026-03-02Kendrick Charles Morgan JRBuy15.87K$294.074.67M
2026-03-02Kendrick Charles Morgan JRBuy2.53K——
2026-03-02Kendrick Charles Morgan JRBuy4.02K——
2026-03-02Kendrick Charles Morgan JRSell1.21K$294.07356.12K
2026-03-02Haytaian Peter DBuy2.87K——
2026-03-02Haytaian Peter DSell1.20K$294.07353.18K
2026-03-02Kaye MarkBuy10.20K——
2026-03-02Kaye MarkBuy25.19K$294.077.41M
2026-03-02Kaye MarkBuy6.38K——
2026-03-02Kaye MarkSell271$294.0779.69K
2026-03-02BOUDREAUX GAILBuy10.53K——
2026-03-02BOUDREAUX GAILBuy16.15K——
2026-03-02BOUDREAUX GAILSell6.71K$294.071.97M
2026-03-02BOUDREAUX GAILBuy63.82K$294.0718.77M
2026-02-02SCHULMAN AMY WBuy218——
2026-02-02Craig Ryan RSell279$341.8395.37K
2026-01-12SCHULMAN AMY WOther0——
2025-10-02Kaye MarkSell2.90K$340.24984.99K
2025-09-03Wessling Erin MSell152$321.5948.88K
2025-09-02Wessling Erin MBuy931——
2025-09-02Wessling Erin MBuy3.54K$322.331.14M
2025-09-02Craig Ryan RBuy970——
2025-09-02Craig Ryan RBuy3.69K$322.331.19M
2025-08-19DeVore Susan D.Buy1.20K$312.15374.58K
2025-08-11Craig Ryan ROther0——
2025-08-11Wessling Erin MOther0——
2025-08-11Wessling Erin MOther394$562.29221.54K
2025-08-11Wessling Erin MOther1.92K$395.50760.15K
2025-08-11Craig Ryan ROther0——
2025-08-11Craig Ryan ROther965$499.11481.64K
2025-08-11Craig Ryan ROther1.20K$395.50475.00K
2025-08-01COLLIS STEVEN HBuy639——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 1.68K, holders +154 vs prior quarter. Ownership 92.37%.

HolderSharesChangeChange %Value
BLACKROCK, INC.18.99M-896.02K-4.51%7.34B
VANGUARD CAPITAL MANAGEMENT LLC14.06M-287.25K-2.00%5.44B
STATE STREET CORP10.43M137.91K+1.34%4.03B
WELLINGTON MANAGEMENT GROUP LLP9.21M984.98K+11.97%3.56B
VANGUARD PORTFOLIO MANAGEMENT LLC6.21M-141.72K-2.23%2.40B
SANDERS CAPITAL, LLC5.83M-69.28K-1.18%2.25B
GEODE CAPITAL MANAGEMENT, LLC5.17M-26.58K-0.51%1.99B
HARRIS ASSOCIATES L P4.92M4.58M+1348.39%1.90B
ARTISAN PARTNERS LIMITED PARTNERSHIP4.58M-545.95K-10.65%1.77B
INVESCO LTD.4.23M-583.18K-12.11%1.64B
FIRST EAGLE INVESTMENT MANAGEMENT, LLC4.19M55.91K+1.35%1.62B
PRICE T ROWE ASSOCIATES INC /MD/4.01M-731.59K-15.41%1.55B
NORGES BANK3.96M3.96MNew1.53B
BANK OF NEW YORK MELLON CORP3.22M377.51K+13.27%1.25B
FMR LLC3.13M1.16M+58.51%1.21B
MORGAN STANLEY2.61M-23.34K-0.89%1.01B
NORTHERN TRUST CORP2.11M-43.04K-1.99%817.93M
CITIGROUP INC2.10M2.10MNew810.92M
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC2.07M-453.08K-17.99%798.81M
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC2.02M-175.36K-8.00%779.73M
GOLDMAN SACHS GROUP INC2.01M529.43K+35.86%775.63M
NUVEEN, LLC1.99M29.16K+1.49%769.54M
MASSACHUSETTS FINANCIAL SERVICES CO /MA/1.94M-300.25K-13.43%749.42M
BANK OF AMERICA CORP /DE/1.81M-912.50K-33.56%698.54M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.80M1.80MNew697.55M

Earnings and financials

Elevance Health Inc. (ELV) trades at $419.46, with a market cap of $90.97B and a trailing P/E of 18.37. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
849784000009003940000092105000000104213000000121867000000138639000000156595000000171340000000176810000000199125000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Elevance Health (ELV) Financials: Revenue & Earnings

ELV$419.46-2.02 -0.48%

$90.97B

Market Cap

18.37

P/E

14.52

Forward P/E

39

Score

Price History